RM attended C2E2, Chicago's Comics and Entertainment Expo, this past weekend at McCormick place. Aside from the costumes, entertainment guests and panels to attend, there was quite a lot of comic book news from some of the biggest brands in the industry: Marvel, DC Comics and Valiant Enterainment. Here's what RM learned this weekened and what you can expect to see soon on shelves at your local comic book shop:

Spencer Pleasant Hill 9425a

Marvel

Marvel announced new titles launching this year, such as Rogue One: A Star Wars Story coming October 2016, along with more details about its Civil War II installments that will be released this summer:

  • Civil War II: Amazing Spider-Man
  • Civil War II: Choosing Sides, a six-issue installment with short stories focused on different characters in the Marvel-verse, including a serialized Nick Fury story in each issue. 
  • Civil War II: Gods of War, a series focusing on Hercules and his role in the Civil War conflict. 
  • The Road to Civil War II, featuring Wolverine and X-23 of the X-Men.
  • Vote Loki, a series where Loki attempts to win the hearts and minds of the U.S. voters as he runs for president.
  • The Unbeatable Squirrel Girl Beats up the Marvel Universe, a graphic novel starring Squirrel Girl coming October 2016.

 

valiant 4001

Valiant Comics

At its panel, Valiant hyped up many upcoming comics, including The Adventures of Archie & Armstrong, Divinity II, Bloodshot Reborrn and Death Mate. Its 4001 AD series also has some exciting things to come, with the company saying things in the comics world will never be the same after these stories are told. There are several titles coming this summer, including:

  • 4001 AD
  • 4001 AD: Blood Shot
  • 4001 AD: X-O Manowar 
  • 4001 AD: RAI

 

DCBOMBS Cv11 c80ce 9c70c

DC Comics

DC may be planning a "rebirth" of its universe, but some of its series will continue on as usual. The DC Bombshells series has been a hit since 2015 with its positive, female-driven message and retro art style. The series was the main focus of the company's hype this weekend with the 11th issue of the series coming out April 13. In addition, DC comics is excited about the next installment of its Wonder Woman Earth One series, which came out this past November. Only a few pages of sketches were previewed at the convention, but it was enough to generate some excitement.

 

See more New &  Notable products here.

By Stephanie Crets

Tags: , ,

newswirelogo

  • SHANGHAI, China, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products that address critical unmet medical needs for patients in Greater China and other parts of Asia, today announced that the first patient has been dosed in a Phase 1b/2 study evaluating FGF401 in combination with PD-1 inhibitor, pembrolizumab, in patients with advanced solid tumors, such as hepatocellular carcinoma (HCC).

  • 中国上海, Aug. 07, 2020 (GLOBE NEWSWIRE) -- 云顶新耀(Everest Medicines),一家专注于创新药开发及商业化的生物制药公司,致力于满足大中华区及其它亚洲市场未被满足的医疗需求,今日宣布在FGF401联合PD-1抑制剂Pembrolizumab用于治疗晚期实体瘤(例如肝细胞癌)的1b/2期临床研究中完成首例受试者给药。

  • HOUSTON, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Houston Wire & Cable Company (NASDAQ: HWCC) (the “Company”) announced operating results for the second quarter ended June 30, 2020 and progress on its cost and debt reduction programs.

  • CAMBRIDGE, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI), a clinical stage biotechnology company focused on developing proprietary technology to harness the power of the immune system to combat cancer, today announced the pricing of its initial public offering of 5,000,000 shares of common stock at a public offering price of $15.00 per share. All of the shares are being offered by Checkmate. Checkmate’s common stock is expected to begin trading on the Nasdaq Global Market under the ticker symbol “CMPI” on August 7, 2020. The gross proceeds of the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Checkmate, are expected to be approximately $75,000,000. The offering is expected to close on August 11, 2020, subject to the satisfaction of customary closing conditions. Checkmate has granted the underwriters a 30-day option to purchase up to an additional 750,000 shares of common stock at the initial public offering price, less the underwriting discounts and commissions.

  • AUSTIN, Texas, Aug. 06, 2020 (GLOBE NEWSWIRE) -- ESW Capital, LLC (“ESW”) – confirms that it has delivered today an application to the Ontario Securities Commission (the “OSC”) for an exemption from the “majority of the minority” requirement contained in Section 2.29.1(c) of National Instrument 62-104 (the “Exemption”) in connection with its previously announced intention to make an offer to acquire any and all subordinate voting shares (the “Shares”) in the capital of Optiva, Inc. (TSX:OPT) (“Optiva”) at the price of CAD $60 per Share (the “Offer”).

Contact Us

Retail Merchandiser Magazine

Cringleford Business Centre,
Intwood Road Cringleford,
Norwich, UK, NR6 4AU

  +44 (0) 1603 274 130

Click here for a full list of contacts.

Back To Top